INSIGHTS ON DRUG DEVELOPMENT

• API In Capsule Vs. The Lost Art Of Formulation Development

  API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.

• How To Capture Growth In The Expanding Metabolic Drug Market

  Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.

• An Alternative Method Of Drug-Excipient Characterization

  Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.

• Using SEC For Reliable Biotherapeutic Peptide Analysis

  Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.

• Scale-Up Of AAV Production In Fixed-Bed Bioreactors

  3/31/2026

  Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.

• CDMOs - Key Collaborators In Streamlining Drug Development

  12/12/2025

  Accelerating biologics development requires more than speed. Discover how the right CDMO partnership can streamline processes and help you reach the market faster without sacrificing control.

• EMA Support For Rare Disease Therapies

  6/10/2025

  Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.

• In Vitro Drug Screening On Cancer Cells

  10/29/2025

  Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.

• How To Power MRD Assessment And Multi-Cancer Detection Research

  6/25/2026

  New advances in MCED and MRD monitoring are transforming cancer care. Fueled by NGS insights, see how these approaches are shifting treatment decisions toward more proactive strategies.